Skip to main content
    S

    Seer Inc (SEER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.48
    -0.09 (-5.73%)

    Market Cap: $87.63M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Seer Inc (SEER) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to SEER are Coherus BioSciences (CHRS), Equillium (EQ) and PDS Biotechnology (PDSB). By market cap, SEER ranks 7th of the 13 companies on this page; Codexis (CDXS) is the largest at $127.13M.

    Peer Comparison

    SEER's revenue growth of -3.4% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Seer (SEER)$87.63MN/A5.8x0.0%N/A-3.4%0.00%
    Coherus BioSciences Inc (CHRS)$81.21MN/A1.5x-253.4%-144.8%23.4%0.00%
    Equillium Inc (EQ)$106.20MN/A29.3x0.0%N/A-52.3%0.00%
    PDS Biotechnology Corp (PDSB)$107.07MN/AN/A0.0%-149.8%0.0%0.00%
    Gossamer Bio Inc (GOSS)$67.10MN/A0.9x-159.5%147.4%189.1%0.00%
    Spero Therapeutics Inc (SPRO)$58.26M11.1x1.3x15.7%N/A-95.6%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    Anixa Biosciences Inc (ANIX)$91.08MN/AN/A0.0%N/A0.0%0.00%
    Heron Therapeuti (HRTX)$59.08MN/A0.4x-14.5%-8.4%-7.8%0.00%
    Serina Therapeutics Inc (SER)$36.93MN/A288.7x0.0%-109.4%154.9%0.00%
    Codexis Inc (CDXS)$127.13MN/AN/A-21.8%N/A124.0%0.00%
    Minerva Neurosciences Inc (NERV)$114.62MN/AN/A0.0%N/A0.0%0.00%
    Pmv Pharmaceuticals Inc (PMVP)$95.93MN/AN/A0.0%N/A0.0%0.00%
    Peer median$86.15M11.1x1.5x0.0%-109.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Seer, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Coherus BioSciences Inc (CHRS)
    Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States.
    CHRS competitors
    Equillium Inc (EQ)
    Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory...
    EQ competitors
    PDS Biotechnology Corp (PDSB)
    PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies.
    PDSB competitors
    Gossamer Bio Inc (GOSS)
    Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing...
    GOSS competitors
    Spero Therapeutics Inc (SPRO)
    Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing...
    SPRO competitors
    iBio, Inc. Common Stock (IBIO)
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors
    Anixa Biosciences Inc (ANIX)
    Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
    ANIX competitors
    Heron Therapeuti (HRTX)
    Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs.
    HRTX competitors
    Serina Therapeutics Inc (SER)
    Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology...
    SER competitors
    Codexis Inc (CDXS)
    Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California.
    CDXS competitors
    Minerva Neurosciences Inc (NERV)
    Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products...
    NERV competitors
    Pmv Pharmaceuticals Inc (PMVP)
    PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53...
    PMVP competitors

    Frequently Asked Questions About SEER

    Who are SEER's main competitors?

    The companies most similar to SEER include Coherus BioSciences (CHRS), Equillium (EQ), PDS Biotechnology (PDSB), Gossamer Bio (GOSS) and Spero Therapeutics (SPRO), listed from the closest match.

    Who is SEER's biggest competitor?

    Codexis (CDXS) is the largest of the similar companies at $127.13M; Coherus BioSciences (CHRS) is the closest match by business profile, size, sector and industry.

    How does SEER stock compare with its competitors?

    SEER's P/S is 5.8x against a peer median of 1.5x; its net margin is 0.0% against a peer median of 0.0%.

    Which of SEER's competitors pays a higher dividend?

    SEER pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is SEER bigger than its competitors?

    No. SEER is 7th by market cap among the 13 companies on this page; the largest is Codexis (CDXS) at $127.13M.